Coronavirus
Coronavirus: BioNTech says no data to support delayed COVID-19 vaccine booster shot
BioNTech and partner Pfizer warned on Monday that they had no evidence that their jointly developed vaccine will continue to protect against COVID-19 if the booster shot is given later than tested in trials.
Visit our dedicated coronavirus site here for all the latest updates.
“The safety and efficacy of the vaccine has not been evaluated on different dosing schedules as the majority of trial participants received the second dose within the window specified in the study design,” the companies said in a joint statement, referring to prime and a booster shots given three weeks apart.
Read more:
Coronavirus: EU drugs agency still undecided on Moderna COVID-19 vaccine
Coronavirus: UK prime minister orders new national lockdown
Coronavirus: New York, Florida tell hospitals to dispense COVID-19 vaccines quicker
Also Read
-
Coronavirus: EU drugs agency still undecided on Moderna COVID-19 vaccine
The European Medicines Agency (EMA) has not been able to reach a decision on the approval of Moderna’s COVID-19 vaccine on Monday, the Dutch national ... Coronavirus -
Coronavirus: UK prime minister orders new national lockdown
British Prime Minister Boris Johnson has announced a new national lockdown for England until at least mid-February to combat a fast-spreading new ... Coronavirus -
Coronavirus: New York, Florida tell hospitals to dispense COVID-19 vaccines quicker
New York state will begin fining hospitals that do not administer allotted COVID-19 vaccines within a week of receiving their supplies and will ... Coronavirus
